{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:44:55Z","timestamp":1767066295965},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2014.75","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T09:55:27Z","timestamp":1415613327000},"page":"e261-e261","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Hypermethylation of the tumor suppressor gene PRDM1\/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma"],"prefix":"10.1038","volume":"4","author":[{"given":"T","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C E","family":"Bacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E M","family":"Queiroga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Gualco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J T","family":"Sample","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Orazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D M","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"key":"BFbcj201475_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev.immunol.26.021607.090241","volume":"26","author":"G Martins","year":"2008","unstructured":"Martins G, Calame K . Regulation and functions of Blimp-1 in T and B lymphocytes. Annu Rev Immunol 2008; 26: 133\u2013169.","journal-title":"Annu Rev Immunol"},{"key":"BFbcj201475_CR2","unstructured":"Tam W . PRDM1 (PR domain containing 1, with ZNF domain). Atlas Genet Cytogenet Oncol Haematol 16: 135\u2013140."},{"key":"BFbcj201475_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1084\/jem.20052204","volume":"203","author":"L Pasqualucci","year":"2006","unstructured":"Pasqualucci L, Compagno M, Houldsworth J, Monti S, Grunn A, Nandula SV et al. Inactivation of the PRDM1\/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 2006; 203: 311\u2013317.","journal-title":"J Exp Med"},{"key":"BFbcj201475_CR4","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1182\/blood-2005-09-3778","volume":"107","author":"W Tam","year":"2006","unstructured":"Tam W, Gomez M, Chadburn A, Lee JW, Chan WC, Knowles DM . Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood 2006; 107: 4090\u20134100.","journal-title":"Blood"},{"key":"BFbcj201475_CR5","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ccr.2010.11.024","volume":"18","author":"DP Calado","year":"2010","unstructured":"Calado DP, Zhang B, Srinivasan L, Sasaki Y, Seagal J, Unitt C et al. Constitutive canonical NF-kappaB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma. Cancer Cell 2010; 18: 580\u2013589.","journal-title":"Cancer Cell"},{"key":"BFbcj201475_CR6","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ccr.2010.10.030","volume":"18","author":"J Mandelbaum","year":"2010","unstructured":"Mandelbaum J, Bhagat G, Tang H, Mo T, Brahmachary M, Shen Q et al. BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer Cell 2010; 18: 568\u2013579.","journal-title":"Cancer Cell"},{"key":"BFbcj201475_CR7","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2353\/ajpath.2010.091291","volume":"177","author":"K Nie","year":"2010","unstructured":"Nie K, Zhang T, Allawi H, Gomez M, Liu Y, Chadburn A et al. Epigenetic down-regulation of the tumor suppressor gene PRDM1\/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7. Am J Pathol 2010; 177: 1470\u20131479.","journal-title":"Am J Pathol"},{"key":"BFbcj201475_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev-immunol-020711-075027","volume":"30","author":"AL Shaffer","year":"2012","unstructured":"Shaffer AL, Young RM, Staudt LM . Pathogenesis of human B cell lymphomas. Annu Rev Immunol 2012; 30: 565\u2013610.","journal-title":"Annu Rev Immunol"},{"key":"BFbcj201475_CR9","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","volume":"118","author":"K Karube","year":"2011","unstructured":"Karube K, Nakagawa M, Tsuzuki S, Takeuchi I, Honma K, Nakashima Y et al. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 2011; 118: 3195\u20133204.","journal-title":"Blood"},{"key":"BFbcj201475_CR10","doi-asserted-by":"publisher","first-page":"20119","DOI":"10.1073\/pnas.1115128108","volume":"108","author":"C Kucuk","year":"2011","unstructured":"Kucuk C, Iqbal J, Hu X, Gaulard P, De Leval L, Srivastava G et al. PRDM1 is a tumor suppressor gene in natural killer cell malignancies. Proc Natl Acad Sci USA 2011; 108: 20119\u201320124.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201475_CR11","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1182\/blood-2013-04-497933","volume":"122","author":"M Boi","year":"2013","unstructured":"Boi M, Rinaldi A, Kwee I, Bonetti P, Todaro M, Tabbo F et al. PRDM1\/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood 2013; 122: 2683\u20132693.","journal-title":"Blood"},{"key":"BFbcj201475_CR12","first-page":"229","volume-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Seto M, Muller-Hermelink HK et al. Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H (eds) WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. IARC: Lyon, France, pp 229\u2013232, 2008."},{"key":"BFbcj201475_CR13","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1182\/blood-2010-08-301556","volume":"117","author":"PP Piccaluga","year":"2011","unstructured":"Piccaluga PP, De Falco G, Kustagi M, Gazzola A, Agostinelli C, Tripodo C et al. Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes. Blood 2011; 117: 3596\u20133608.","journal-title":"Blood"},{"key":"BFbcj201475_CR14","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1182\/blood-2005-01-0168","volume":"106","author":"C Bellan","year":"2005","unstructured":"Bellan C, Lazzi S, Hummel M, Palummo N, de Santi M, Amato T et al. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 2005; 106: 1031\u20131036.","journal-title":"Blood"},{"key":"BFbcj201475_CR15","first-page":"434","volume":"91","author":"G Cattoretti","year":"2006","unstructured":"Cattoretti G . PRDM1\/BLIMP-1 expression in lymphomas. Haematologica 2006; 91: 434\u2013435.","journal-title":"Haematologica"},{"key":"BFbcj201475_CR16","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/ijc.24655","volume":"126","author":"E Leucci","year":"2010","unstructured":"Leucci E, Onnis A, Cocco M, De Falco G, Imperatore F, Giuseppina A et al. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression. Int J Cancer 2010; 126: 1316\u20131326.","journal-title":"Int J Cancer"},{"key":"BFbcj201475_CR17","doi-asserted-by":"publisher","first-page":"5907","DOI":"10.1182\/blood-2010-09-307710","volume":"117","author":"K Vrzalikova","year":"2011","unstructured":"Vrzalikova K, Vockerodt M, Leonard S, Bell A, Wei W, Schrader A et al. Down-regulation of BLIMP1alpha by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas. Blood 2011; 117: 5907\u20135917.","journal-title":"Blood"},{"key":"BFbcj201475_CR18","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/bioinformatics\/18.11.1427","volume":"18","author":"LC Li","year":"2002","unstructured":"Li LC, Dahiya R . MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18: 1427\u20131431.","journal-title":"Bioinformatics"},{"key":"BFbcj201475_CR19","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1093\/bioinformatics\/bti652","volume":"21","author":"C Bock","year":"2005","unstructured":"Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T . BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 2005; 21: 4067\u20134068.","journal-title":"Bioinformatics"},{"key":"BFbcj201475_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2353\/ajpath.2008.080009","volume":"173","author":"K Nie","year":"2008","unstructured":"Nie K, Gomez M, Landgraf P, Garcia JF, Liu Y, Tan LH et al. MicroRNA-mediated down-regulation of PRDM1\/Blimp-1 in Hodgkin\/Reed\u2013Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol 2008; 173: 242\u2013252.","journal-title":"Am J Pathol"},{"key":"BFbcj201475_CR21","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm1002-1086","volume":"8","author":"SH Speck","year":"2002","unstructured":"Speck SH . EBV framed in Burkitt lymphoma. Nat Med 2002; 8: 1086\u20131087.","journal-title":"Nat Med"},{"key":"BFbcj201475_CR22","first-page":"265","volume-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues","author":"PM Kluin","year":"2008","unstructured":"Kluin PM, Harris NL, Stein H, Leoncini L, Raphael M, Campo E et al. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. IARC: Lyon, France, pp 265\u2013266, 2008."},{"key":"BFbcj201475_CR23","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.4049\/jimmunol.173.2.1158","volume":"173","author":"C Tunyaplin","year":"2004","unstructured":"Tunyaplin C, Shaffer AL, Angelin-Duclos CD, Yu X, Staudt LM, Calame KL . Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol 2004; 173: 1158\u20131165.","journal-title":"J Immunol"},{"key":"BFbcj201475_CR24","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1128\/jvi.63.7.3135-3141.1989","volume":"63","author":"MG Masucci","year":"1989","unstructured":"Masucci MG, Contreras-Salazar B, Ragnar E, Falk K, Minarovits J, Ernberg I et al. 5-Azacytidine up regulates the expression of Epstein\u2013Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael. J Virol 1989; 63: 3135\u20133141.","journal-title":"J Virol"},{"key":"BFbcj201475_CR25","doi-asserted-by":"publisher","first-page":"6150","DOI":"10.1128\/MCB.15.11.6150","volume":"15","author":"KD Robertson","year":"1995","unstructured":"Robertson KD, Hayward SD, Ling PD, Samid D, Ambinder RF . Transcriptional activation of the Epstein\u2013Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol Cell Biol 1995; 15: 6150\u20136159.","journal-title":"Mol Cell Biol"},{"key":"BFbcj201475_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12185-009-0472-5","volume":"91","author":"A Hangaishi","year":"2010","unstructured":"Hangaishi A, Kurokawa M . Blimp-1 is a tumor suppressor gene in lymphoid malignancies. Int J Hematol 2010; 91: 46\u201353.","journal-title":"Int J Hematol"},{"key":"BFbcj201475_CR27","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/leu.2009.3","volume":"23","author":"J Iqbal","year":"2009","unstructured":"Iqbal J, Kucuk C, Deleeuw RJ, Srivastava G, Tam W, Geng H et al. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia 2009; 23: 1139\u20131151.","journal-title":"Leukemia"},{"key":"BFbcj201475_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/path.1752","volume":"206","author":"G Cattoretti","year":"2005","unstructured":"Cattoretti G, Angelin-Duclos C, Shaknovich R, Zhou H, Wang D, Alobeid B . PRDM1\/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage. J Pathol 2005; 206: 76\u201386.","journal-title":"J Pathol"},{"key":"BFbcj201475_CR29","doi-asserted-by":"publisher","first-page":"e1000492","DOI":"10.1371\/journal.ppat.1000492","volume":"5","author":"K Paschos","year":"2009","unstructured":"Paschos K, Smith P, Anderton E, Middeldorp JM, White RE, Allday MJ . Epstein\u2013Barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathogen 2009; 5: e1000492.","journal-title":"PLoS Pathogen"},{"issue":"Part 10","key":"BFbcj201475_CR30","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1099\/vir.0.81906-0","volume":"87","author":"AI Bell","year":"2006","unstructured":"Bell AI, Groves K, Kelly GL, Croom-Carter D, Hui E, Chan AT et al. Analysis of Epstein\u2013Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J Gen Virol 2006; 87 (Part 10): 2885\u20132890.","journal-title":"J Gen Virol"},{"key":"BFbcj201475_CR31","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V91.4.1373","volume":"91","author":"Q Tao","year":"1998","unstructured":"Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF . Epstein\u2013Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood 1998; 91: 1373\u20131381.","journal-title":"Blood"},{"key":"BFbcj201475_CR32","doi-asserted-by":"publisher","first-page":"901","DOI":"10.4161\/cc.9.5.10840","volume":"9","author":"KT Bieging","year":"2010","unstructured":"Bieging KT, Swanson-Mungerson M, Amick AC, Longnecker R . Epstein\u2013Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A. Cell Cycle 2010; 9: 901\u2013908.","journal-title":"Cell Cycle"},{"key":"BFbcj201475_CR33","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.4049\/jimmunol.177.5.2793","volume":"177","author":"H Wang","year":"2006","unstructured":"Wang H, Nicholas MW, Conway KL, Sen P, Diz R, Tisch RM et al. EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol 2006; 177: 2793\u20132802.","journal-title":"J Immunol"},{"key":"BFbcj201475_CR34","doi-asserted-by":"publisher","first-page":"11191","DOI":"10.1128\/JVI.00983-06","volume":"80","author":"AM Shore","year":"2006","unstructured":"Shore AM, White PC, Hui RC, Essafi A, Lam EW, Rowe M et al. Epstein\u2013Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2A. J Virol 2006; 80: 11191\u201311199.","journal-title":"J Virol"},{"key":"BFbcj201475_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.coi.2008.04.010","volume":"20","author":"K Calame","year":"2008","unstructured":"Calame K . Activation-dependent induction of Blimp-1. Curr Opin Immunol 2008; 20: 259\u2013264.","journal-title":"Curr Opin Immunol"},{"key":"BFbcj201475_CR36","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","volume":"79","author":"LL Laichalk","year":"2005","unstructured":"Laichalk LL, Thorley-Lawson DA . Terminal differentiation into plasma cells initiates the replicative cycle of Epstein\u2013Barr virus in vivo. J Virol 2005; 79: 1296\u20131307.","journal-title":"J Virol"},{"key":"BFbcj201475_CR37","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nrmicro2015","volume":"6","author":"DA Thorley-Lawson","year":"2008","unstructured":"Thorley-Lawson DA, Allday MJ . The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol 2008; 6: 913\u2013924.","journal-title":"Nat Rev Microbiol"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj201475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201475","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T22:04:04Z","timestamp":1717538644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,7]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11]]}},"alternative-id":["BFbcj201475"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2014.75","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,7]]},"assertion":[{"value":"30 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}